Log In
Print
BCIQ
Print
Print this Print this
 

SCOUT DS

  Manage Alerts
Collapse Summary General Information
Company Miraculins Inc.
DescriptionNoninvasive device that measures skin fluorescence to detect biological markers found in skin related to cumulative glycemic exposure, oxidative stress and microvascular changes
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationEndocrine, Diagnostic
Indication DetailsScreen adults who are at risk for prediabetes and/or Type II diabetes to determine whether diagnostic testing is necessary
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today